Effect of dexamethasone on cyclophosphamide-induced cystitis in rats: Lack of relation with bradykinin B1 receptor-mediated motor responses

European Journal of Pharmacology

Volumn 369, Issue 1, 1999, Pages 99-106

  Lecci, Alessandro ^a   Meini, Stefania ^a   Patacchini, Riccardo ^a   Tramontana, Manuela ^a   Giuliani, Sandro ^a   Criscuoli, Marco ^a   Maggi, Carlo Alberto ^a  

^a Pharmacology Department   (Italy)

Author keywords

Bladder compliance; Bradykinin B1 receptor binding; Bradykinin B2 receptor binding; Des Arg10 Hoe 140; Hoe 140; Inflammation; Kinin; Urinary bladder

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ DERIVATIVE; BRADYKININ[1-8]; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ICATIBANT; KALLIDIN[1-9]; KININ;

ANIMAL EXPERIMENT; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; CONTROLLED STUDY; CYSTITIS; DRUG EFFECT; DRUG RECEPTOR BINDING; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BINDING, COMPETITIVE; BRADYKININ; CARCINOGENS; CYCLOPHOSPHAMIDE; CYSTITIS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; KALLIDIN; MALE; MUSCLE CONTRACTION; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ; TRITIUM; URINARY BLADDER;

EID: 0033064242     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00052-7     Document Type: Article

References (33)

1. Ahluwalia A., Maggi C.A., Santicioli P., Lecci A., Giuliani S. Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br. J. Pharmacol. 111:1994;1017-1022.
2. Bacci E., Bertrand C., Geppetti P., Baker J., Nadel J.A., Laitinen L.A., Petersson G. Budesonide inhibits plasma extravasation induced by capsaicin and by substance P in the rat nasal mucosa. Regulatory Peptides. 49:1993;159-166.
3. 1 receptor gene: evidence for variable tissue expression and alternative splicing. The 15th International Conference on Kinins, Nara, Japan, October 19-24, 1998.
4. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1992;1-80.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 75:1976;248-254.
6. 9-bradykinin. Br. J. Pharmacol. 93:1988;869-977.
7. Flower R.J. Lipocortin and the mechanism of action of glucocorticoids. Br. J. Pharmacol. 94:1988;987-1015.
8. Haynes, R.C., Jr., 1990. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman Gilman, A., Rall, T.W., Nies, A.S., Taylor, P. (Eds.), The Pharmacological Basis of Therapeutics, 8th edn., Pergamon, New York, pp. 1431-1462.
9. Hess, J.F., 1997. Molecular pharmacology of kinin receptors. In: Farmer, S.G. (Ed.), The Kinin System, Academic Press, London, pp. 45-55.
10. Huicochea Grobet Z.L., Berron R., Ortega Martell J.A., Onuma E. Survival up to 5 and 10 years of mexican pediatric patients with systemic lupus erythematosus: overview of 23 years experience. Allergologia Immunopathologia. 24:1996;36-38.
11. Iidia N., Sugiyama A., Myoubudani H., Inoue K., Sugamata M., Ihara T., Ueno Y., Tashiro F. Suppression of arachidonic acid cascade-mediated apoptosis in aflatoxin B1-induced rat hepatoma cells by glucocorticoids. Carcinogenesis. 19:1998;1191-1202.
12. 2 receptor antagonists upon viscero-visceral hyperreflexia in a rat model of visceral hyperalgesia. Pain. 75:1998;169-176.
13. 2 activity: evidence for glucocorticoid receptor-mediated regulation. Mol. Cell. Endocrinol. 137:1998;117-125.
14. Lecci, A., Maggi, C.A., 1996. Sensory neuropeptides in the lower urinary tract. In: Geppetti, P., Holzer, P. (Eds.), Neurogenic Inflammation, CRC Press, Boca Raton, FL, pp. 201-209.
15. 2 receptors. Neuropeptides. 27:1994;53-62.
16. Lecci A., Giuliani S., Meini S., Maggi C.A. Pharmacological analysis of the local and reflex responses to bradykinin on the rat urinary bladder motility in vivo. Br. J. Pharmacol. 114:1995;708-714.
17. 1 receptor-mediated responses in normal or inflamed rat urinary bladder in vivo. Br. J. Pharmacol. 124:1998;85P.
18. 1 receptors in the rat urinary bladder of cyclophosphamide-treated rats. The 15th International Conference on Kinins, Nara, Japan, October 19-24, 1998.
19. Maggi, C.A., 1997. Bradykinin as an inflammatory mediator in the urinary tract. In: Farmer, S. (Ed.), The Kinin System, Academic Press, London, pp. 235-247.
20. Maggi C.A., Lecci A., Santicioli P., Del Bianco E., Giuliani S. Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. J. Auton. Nerv. Syst. 38:1992;201-208.
21. Maggi C.A., Santicioli P., Del Bianco E., Lecci A., Giuliani S. Evidence for the involvement of bradykinin in chemically-evoked cystitis in anaesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;432-437.
22. 1 receptors: a review. Immunopharmacology. 30:1995;1-26.
23. Marceau F., Barabé J., St-Pierre S., Regoli D. Kinin receptors in experimental inflammation. Can. J. Physiol. Pharmacol. 58:1980;536-542.
24. 1 receptors for kinins. Pharmacol. Rev. 50:1998;357-386.
25. 1 receptors. Br. J. Pharmacol. 117:1996;1619-1624.
26. Meini S., Lecci A., Cucchi P., Catalioto R.-M., Criscuoli M., Maggi C.A. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists. J. Pharmacol. Exp. Ther. 287:1998;137-143.
27. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
28. Rosamilia, A., Duncan, A.-M., Kaldis, A., Kruithof, S., Briscoe, T., Doery, J., Clements, J., Campbell, D.J., 1998. Activation of the kallikrein-kinin system in interstitial cystitis. The 15th International Conference on Kinins, Nara, Japan, October 19-24, 1998.
29. Stewart A. Optimal control of cyclophosphamide-induced emesis. Oncology. 53:1996;32-38. Suppl. 1.
30. Taylor C.W., Dalton W.S., Mosley K., Dorr R.T., Salmon S.E. Combination chemotherapy with cyclophosphamide, vincristine, adriamycin and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer. Breast Cancer Res. Treat. 42:1997;7-14.
31. Watson N.A., Notley R.G. Urological complications of cyclophosphamide. Br. J. Urol. 45:1973;606-609.
32. 1 receptor antagonist. Eur. J. Pharmacol. 205:1991;217-218.
33. Wirth K., Hock F.J., Albus U., Linz W., Alpermann H.G., Anagnastopulos H., Henke S., Breiphol G., König W., Knolle J., Schölkens B. Hoe 140 a new potent and long-acting bradykinin antagonist: in vivo studies. Br. J. Pharmacol. 102:1991;774-777.